Trending

    Everest Group Life Sciences Digital Services Specialists PEAK Matrix® Assessment 2024

    We’re proud to have been named a Leader in the Everest Group Life Sciences Digital Services Specialists PEAK Matrix® Report. Everest Group classified ...

    Learn More
    From Chaos to Cohesion
    How Will The Next Great Recession Affect The US Pharma Industry?

    How Will The Next Great Recession Affect The US Pharma Industry?

    The US will have another recession as certain as night follows day. The business cycle has not been outlawed nor made extinct, contrary to the overly optimistic views of macroeconomists who think they have mastered the science and art of counter-cyclical monetary and fiscal policies. The macroeconomic environment for pharma companies is an exogenous factor beyond the capability of any individual ...
    Learn More
    Perspectives On Pharma Company Use Of Open Payments Data

    Perspectives On Pharma Company Use Of Open Payments Data

    The creation of Open Payments Data (OPD) was formed from the Affordable Care Act to bring greater public transparency to the financial relationships between pharma and medical device companies, and healthcare providers. This white paper provides a detailed analysis on the role and effects of “Sunshine Laws” and payments made to providers as seen from published empirical evidence, intricacies, and ...
    Learn More
    How Will The 2018 Midterm Congressional Election Results Affect The US Pharma Industry?

    How Will The 2018 Midterm Congressional Election Results Affect The US Pharma Industry?

    The 2018 Congressional midterm elections are over after a bitter political fight. The voters have spoken. We are back to divided government, with Democrats controlling the House, and Republicans expanding their majority in the Senate. Will there be bipartisan collaboration or political conflict and policy immobilism? This paper provides a detailed analysis why the US pharma industry, specifically ...
    Learn More
    Is The CVS-Aetna Merger A Pharma Industry Transformative Event?

    Is The CVS-Aetna Merger A Pharma Industry Transformative Event?

    US antitrust officials recently approved the proposed $69 billion CVS-Aetna merger. This merger follows a similar action taken by the Justice Department to approve the Cigna-Express Scripts merger, and partnering activities by Amazon, Berkshire Hathaway, and J.P. Morgan to get into the healthcare industry. These events taken together suggest what some have characterized as “the era of retail ...
    Learn More
    The Value Of Machine Learning And Data Mining In Pharmaceutical Commercial Analytics

    The Value Of Machine Learning And Data Mining In Pharmaceutical Commercial Analytics

    It is widely believed that machine learning and data mining are right on the cusp of becoming among the most important breakthroughs that the healthcare industry has seen in years. While applications of these techniques have already occurred elsewhere in the pharma sector, wide-spread applications in pharmaceutical commercial analytics have come more recently. Pharma companies are now looking to ...
    Learn More
    The Evolution Of Pharmaceutical Call Planning

    The Evolution Of Pharmaceutical Call Planning

    Access to Healthcare Practitioners (HCPs) continues to be restricted in this ever-evolving healthcare ecosystem. Contact with stakeholders is typically limited due to stringent anti-rep policies and their organization’s rules and guidelines. This calls for new ways to reach these stakeholders and the evolution of pharmaceutical call planning. This white paper explores the factors used to develop ...
    Learn More
    Are Pharmaceutical Direct-To-Consumer TV Ads Appropriate In An Industry Environment Focused On Specialty Medicines? A Commentary

    Are Pharmaceutical Direct-To-Consumer TV Ads Appropriate In An Industry Environment Focused On Specialty Medicines? A Commentary

    No pharmaceutical topic causes as much passionate difference of opinions between industry and medical community representatives as the practice of direct-to-consumer advertising (DTCA), with the likely exception being drug pricing. Despite criticisms and the heated debate on the appropriateness of this channel, DTCA spending continues to grow. The drug industry spent approximately $5.6 billion on ...
    Learn More
    Decision Science Asset Diversification Versus Concentration In An Evolving Pharmaceutical Market

    Decision Science Asset Diversification Versus Concentration In An Evolving Pharmaceutical Market

    The pharmaceutical industry continues to undergo tremendous changes. The questions for executives are how do these changes affect the direction of investments in new decision science technologies and whether there should be focus on certain areas of expertise that are felt to offer a competitive advantage for the company? These choices in the direction of investments are embodied in the title of ...
    Learn More
    Sales Analytics And Big Data Developments Needed Now To Address Practitioner-Identified Emerging Biopharmaceutical Sales Force Strategic And Operational Issues

    Sales Analytics And Big Data Developments Needed Now To Address Practitioner-Identified Emerging Biopharmaceutical Sales Force Strategic And Operational Issues

    The biopharmaceutical industry is undergoing significant changes. Most importantly, there is a shift toward greater company R&D focus on and launching of specialty medicines that use new scientific drug delivery systems, e.g., large molecules as opposed to traditional small molecule drugs, catering to smaller patient populations. While this shift solves some problems pharma has been facing, ...
    Learn More